Joincare Pharmaceutical Group Industry Co., Ltd

This study tests a new flu medicine called JKN2301 in children aged 2 to 11 who have the flu. The goal is to see if it safely reduces symptoms like fever and helps kids feel better faster. About 177 children will take part, and the medicine is given as a liquid that can be swallo…

This study tests a new daily pill, JKN2403, in 120 adults with moderate-to-severe COPD. The goal is to see if it reduces serious flare-ups and improves breathing and quality of life compared to a placebo. Participants take the pill or placebo for 24 weeks and visit the clinic mon…

This early-stage study is testing a new drug called JKN2501 in 66 healthy adults in China to see if it is safe and how the body processes it. The drug is being developed to fight bacterial infections like urinary tract, lung, and abdominal infections. Participants will receive ei…